Glenview Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Sell
150,556
-26,352
-15% -$2.06M 0.2% 101
2025
Q1
$12.8M Sell
176,908
-180,654
-51% -$13.1M 0.25% 97
2024
Q4
$26.5M Sell
357,562
-57,982
-14% -$4.29M 0.5% 47
2024
Q3
$27.4M Sell
415,544
-11,215
-3% -$740K 0.53% 44
2024
Q2
$39.4M Buy
426,759
+19,770
+5% +$1.83M 0.79% 30
2024
Q1
$38.9M Buy
406,989
+20,266
+5% +$1.94M 0.84% 26
2023
Q4
$29.5M Sell
386,723
-3,959
-1% -$302K 0.72% 38
2023
Q3
$27.1M Buy
390,682
+29,436
+8% +$2.04M 0.75% 36
2023
Q2
$34.1M Buy
361,246
+19,424
+6% +$1.83M 0.93% 28
2023
Q1
$28.3M Buy
341,822
+22,017
+7% +$1.82M 0.85% 34
2022
Q4
$23.9M Buy
319,805
+148,341
+87% +$11.1M 0.79% 37
2022
Q3
$14.2M Sell
171,464
-5,900
-3% -$488K 0.54% 56
2022
Q2
$16.9M Sell
177,364
-16,233
-8% -$1.54M 0.62% 48
2022
Q1
$22.8M Sell
193,597
-33,156
-15% -$3.9M 0.74% 36
2021
Q4
$29.4M Sell
226,753
-35,749
-14% -$4.63M 0.97% 25
2021
Q3
$29.7M Sell
262,502
-13,430
-5% -$1.52M 1.15% 21
2021
Q2
$28.6M Buy
275,932
+12,243
+5% +$1.27M 1.1% 24
2021
Q1
$22.1M Buy
263,689
+2,635
+1% +$220K 0.95% 32
2020
Q4
$23.8M Buy
261,054
+117
+0% +$10.7K 1.11% 23
2020
Q3
$20.8M Sell
260,937
-967
-0.4% -$77.2K 1.08% 27
2020
Q2
$18.1M Buy
261,904
+14,113
+6% +$975K 1.03% 29
2020
Q1
$15.6M Buy
247,791
+8,709
+4% +$548K 1.08% 25
2019
Q4
$18.6M Sell
239,082
-2,946
-1% -$229K 1.04% 28
2019
Q3
$17.7M Sell
242,028
-5,649
-2% -$414K 1.07% 28
2019
Q2
$15.3M Buy
247,677
+6,120
+3% +$377K 0.95% 30
2019
Q1
$15.4M Buy
241,557
+4,089
+2% +$261K 0.99% 28
2018
Q4
$12.1M Buy
237,468
+5,991
+3% +$306K 0.9% 32
2018
Q3
$13.4M Buy
+231,477
New +$13.4M 0.85% 33
2018
Q2
Sell
-225,081
Closed -$10.5M 322
2018
Q1
$10.5M Buy
225,081
+15,219
+7% +$708K 0.72% 39
2017
Q4
$7.89M Buy
209,862
+34,329
+20% +$1.29M 0.54% 62
2017
Q3
$6.4M Buy
175,533
+153,306
+690% +$5.59M 0.47% 77
2017
Q2
$876K Hold
22,227
0.07% 174
2017
Q1
$697K Sell
22,227
-840
-4% -$26.3K 0.06% 192
2016
Q4
$720K Buy
+23,067
New +$720K 0.06% 184
2015
Q4
$493K Buy
+18,732
New +$493K 0.05% 180